DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues

Cristina Gallego-Fabrega1,2, Natalia Cullell1,2,3, Carolina Soriano-Tárraga4

  • 1Neurology, Hospital Universitari Mútua de Terrassa/Fundacio Docència i Recerca MutuaTerrassa, Terrassa, Spain.

Oncotarget
|March 25, 2020
PubMed
Abstract

Insights

DNA methylation patterns in Matrix Metalloproteinases (MMP) and Tissue Inhibitor of Metalloproteinases (TIMP) genes differ between stable and unstable carotid plaques. These DNA methylation changes, particularly in MMP24, are also observed in blood samples from patients with atherothrombotic stroke.

Area of Science:

  • Epigenetics
  • Cardiovascular Biology
  • Genomics

Background:

  • Matrix Metalloproteinases (MMP) and Tissue Inhibitor of Metalloproteinases (TIMP) are implicated in atheromatous plaques and ischemic stroke.
  • Previous research focused on polymorphisms and serum levels, neglecting DNA methylation patterns of MMP and TIMP genes.

Purpose of the Study:

  • To investigate DNA methylation (DNAm) levels of MMP and TIMP gene families in human carotid plaques and blood samples from atherothrombotic stroke patients.
  • To identify specific DNAm patterns associated with plaque stability and stroke risk.

Main Methods:

  • DNAm status of stable and unstable atherosclerotic carotid plaques from three patients was profiled.
  • 415 CpG sites in MMP and TIMP genes were analyzed.
  • Associated CpG sites were further analyzed in blood samples from two atherothrombotic stroke cohorts (n=307) using high-density microarrays.

Main Results:

  • Three CpG sites showed significant association with unstable plaque portions: cg02969624 (TIMP2) and cg04316754 (MMP24) were hypermethylated, while cg24211657 (TIMP2) was hypomethylated.
  • Methylation levels of cg04316754 (MMP24) in blood samples correlated with atherothrombotic risk in both stroke cohorts (p=0.03 and p=1.9 × 10⁻⁰⁴).

Conclusions:

  • DNA methylation patterns of MMP24 differ between stable and unstable atherothrombotic carotid plaques.
  • Distinct DNA methylation profiles in blood samples differentiate atherothrombotic stroke patients from controls, particularly involving MMP24.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
680
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
297
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
610